Peer Review History
| Original SubmissionDecember 6, 2022 |
|---|
|
PONE-D-22-33518Simultaneous analytical method for 296 pesticide multiresidues in root and rhizome based herbal medicines using GC-MS/MSPLOS ONE Dear Dr. Choi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== This article describes the development of an analytical method allowing the determination of 296 pesticides in medicinal plant samples by GC-MS/MS. The objective of the study is clear and of major interest because the plants studied are used as medicines in Asian countries but also in Western countries. This article has been evaluated by 2 independent reviewers (see reports below). In view of these different feedbacks, major revisions are requested for this article. In summary, this decision is based on 2 major aspects which are important criterias for publication in plos one: - methodologically: it is essential to better describe the "pesticide-free" reference matrix. How was it qualified as pesticide-free? What method was used to check this? How is it produced? These elements of precision are key technical points for the validation of the detection method. - at the level of the discussion: this one will have to be deepened to put in perspective the measured levels of contaminants and/or residues with the literature, with the possible available reference values and/or with the possible regulatory values (maximum residual limits, acceptable daily dose). This reflection is essential to determine if the levels observed are significant and could have a health impact. The remarks of the rapporteurs are detailed below and should all be taken into account in the revised article. If some of the reviewers' comments cannot be considered the authors should justify why this is not possible. ============================= Please submit your revised manuscript by Mar 09 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Christine Demeilliers Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf 2. Thank you for stating in your Funding Statement: "This study was supported by a grant (21172MFDS149) from the Ministry of Food and Drug Safety in 2021." Please provide an amended statement that declares *all* the funding or sources of support (whether external or internal to your organization) received during this study, as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now. Please also include the statement “There was no additional external funding received for this study.” in your updated Funding Statement. Please include your amended Funding Statement within your cover letter. We will change the online submission form on your behalf. 3. Thank you for stating the following financial disclosure: "This study was supported by a grant (21172MFDS149) from the Ministry of Food and Drug Safety in 2021." Please state what role the funders took in the study. If the funders had no role, please state: ""The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."" If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 4. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: I Don't Know ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Please refer to the attached file for comment. I used the tracking function. Main Comment The pesticide detection rate is very high. Is PHI and MRL set for the detected pesticide? The author should consider using this. Reviewer #2: The authors describe an analytical method development dedicated to 296 pesticides in three herbal samples using GC-MS/MS. The experimental work is impressive and of good quality and focuses on: optimization of the extraction solvent, influence of complementary acidic conditions on the extraction process, further clean-up of the samples. The purpose of this study is of a great interest as it is suggested that the considered herbals are traditionally used as medicines and have become popular in Western countries. Therefore, the introduction should describe in more details 1) the choice of the herbal medicines, 2) the choice of the pesticides studied, 3) the rules related to the use of such medicines at least in China and Korea. For example, the maximum residue limits are said to be slightly different in herbal medicines than in common crop but not given. Moreover even if no official rule is said to regulate the targeted compounds, an order of magnitude of the acceptable daily intake of pesticides residues according to the local pharmacopeia would be appreciated. When developing the choice of the extraction solvents, more details on the chemical composition of herbal matrix is needed: why is it so different from common crops? Acetonitrile is considered as an extraction solvent used in the QuEChERS method whereas strictly speaking it does not allow two phases in an aqueous sample. The mixture of acetonitrile with an extraction solvent chose as ethyl acetate is expected to combine strength of both solvents: a reference or explanation is needed here. The material and method part is well described but a doubt remains considering the specificity of the method: the “pesticide-free” herbal medicines are used as a blank matrix. How are these herbal medicines produced? How is the absence of all the 296 pesticides determined at the level of sensitivity described later in the paper. It suggests that the company from which these pesticide-free were purchased is able to quantify the targeted pesticides. The experimental conditions used for the GC-MS/MS analysis should be referenced. The results and discussion part is clear and pertinent but: - p10 - The choice of the ACN/EA ratio should be documented: why 3/7 and not 4/6, 5/5? Is it based from previous work? - p11 - How does the study show that EA is more likely to co-extract interferences that ACN? - Figures are blurred and red could not be seen apart from SI ones - p11 - Tiometon is described but not visible from fig. 2 - figS2 shows a mean relative standard deviation over the 296 pesticides but no error bars are seen - p15 - The method validation should be referenced or described in more details as only the performances in terms of LOQ is here given. If the MRL are available for some compounds, they should be given or referenced. - p22 – is FigS4 meant after the whole treatment? The method is finally applied to samples obtained from commercial markets with nice performances. It highlights that and the 296 targeted compounds, a maximum of 10 where detected beyond the LOQ in of the herbal medicine. More details would be appreciated here about the origin of the samples: not only the country but also the method of cultivation, of sampling, of storage...are these results of concern in terms of health risk? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.
|
| Revision 1 |
|
PONE-D-22-33518R1Simultaneous analytical method for 296 pesticide multi-residues in root and rhizome based herbal medicines with GC-MS/MSPLOS ONE Dear Dr. Choi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Jun 16 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Totan Adak Academic Editor PLOS ONE Journal Requirements: 1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Additional Editor Comments: I have assessed the manuscript entitled "Simultaneous analytical method for 296 pesticide multi-residues in root and rhizome based herbal medicines with GC-MS/MS". Please find my comments below in addition to the comments of the reviewers. Following are major suggestions: 1. Thorough English editing is needed. Difficult to follow the write up. For example, see the line number 29-30 in abstract. I am unable to comprehend. 2. MM section needs to be rewritten: a. What is n=9, n=3 so on? Elaborate. b. Clean up agents: GCB in dspe tube as mentioned in materials/reagents does not match in this section. c. A proper description on HLB cartridge should be given. How were they preconditioned? What was the suction? Which solvent was used to elute etc. Please see any previous paper. d. In sample preparation, both cartridge and alumina were used? Nothing is mentioned in MM. Should be mentioned here. Why it was chosen? with whom it was compared? e. Before injection to GCMS, the centrifuged material should have been filtered. f. Please clarify how are going to get a concentration of 2.5 ng/ml in extract at 10 ppb fortification. g. Why you have not used any water to saturate the sample? There are several advantages of using water. In addition, the recovery of extract (ACN/EA) will be very less in dry sample. h. Nothing is mentioned on Matrix of three medicinal plants in MM section. whereas, most of the RD section is comparison of the three matrices. i. Any statistics 3. Result: a. At different time segments, pulsed injection pressure had different results? Why? No discussion is made. b. Using EA, authors invited co-extracts as pointed out by the reviewers. Using water for saturation, this could have been avoided. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #3: Partly ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: N/A Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #3: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: (No Response) Reviewer #3: 1. Authors have specified LOQ as low as 0.002 ppm for most of the pesticides analysed. But the recovery tested were well above the respective LOQ values, which is a mandatory requirement for method validation. Authors have quantified the pesticides at above LOQ level but the recovery at LOQ level is lacking. The supporting information in form of tested results may be supplied for more accuracy of the method. 2. The choice of solvents for extraction in a ratio has been already addressed by previous reviewers. The authors have tried to answer, but I have a doubt about the solubility of the pesticides in the mixture. Can the authors discuss about this. 3. As regards to the clean up steps, the authors have utilised alumina to remove the co-extractives. But, the authors have addressed the reviewers question, stating that ethyl acetate results in more extraction of co-extractives, as observed in increased dry weight. This creates ambiguity. The authors have first increased the co-extractives through extraction and then they are trying to remove the co-extractives using alumina. This requires justification. 4. TIC of control samples are presented but they should have also presented the TIC of fortified matrix. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Hyun Ho Noh Reviewer #3: Yes: ABHIJIT KAR ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 2 |
|
Simultaneous analytical method for 296 pesticide multiresidues in root and rhizome based herbal medicines with GC-MS/MS PONE-D-22-33518R2 Dear Dr. Choi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Totan Adak Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-22-33518R2 Simultaneous analytical method for 296 pesticide multiresidues in root and rhizome based herbal medicines with GC-MS/MS Dear Dr. Choi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Totan Adak Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .